netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 5: Infections - Full Chapter
Notes:
This section advises on the choice of anti-infective agents available at each Trust.  Doctors should refer to local or departmental antibiotic  guidelines for advice regarding specific treatments within specialised  units (including prophylaxis for surgical, medical and dental  procedures). Different antibiotic policies can be found in different  hospitals due to local variations in resistance and antibiotic  susceptibility.

M: Use of this agent only to be initiated under the advice of a  microbiologist or virologist as appropriate.

S: Use of this agent only to be initiated under the advice of a relevant clinical specialist.
Chapter Links...
 Details...
05.04.01  Expand sub section  Antimalarials
Artesunate injection
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Red
At GSTFT, use in accordance with the guideline “Management of Malaria in Adults” First-line therapy for severe falciparum malaria in non-pregnant adults 
   
05.04.01  Expand sub section  Artemether with lumefabtrine
Artemether with lumefantrine tabs (Riamet®)
View adult BNF View SPC online
Formulary  
   
05.04.01  Expand sub section  Chloroquine
Chloroquine tabs, syrup, injection
View adult BNF View SPC online
Formulary Injection = Red Traffic Light  
   
05.04.01  Expand sub section  Mefloquine
Mefloquine tabs
View adult BNF View SPC online
Formulary  
   
05.04.01  Expand sub section  Primaquine to top
Primaquine tabs
View adult BNF View SPC online
Formulary  
   
Primaquine tabs
View adult BNF View SPC online
Unlicensed Drug Unlicensed Prevention of subsequent relapse of non-falciparum malaria Dose: Orally 15 mg daily for 14 days following the treatment of P. vivax and P. ovale malaria. Please seek expert advice for G6PD deficient individuals and cases where relapse occurs despite primaquine therapy 
   
Primaquine tabs
View adult BNF View SPC online
Unlicensed Drug Unlicensed PCP treatment in accordance with BHIVA guidelines Dose: 15-30 mg once daily 
   
05.04.01  Expand sub section  Proguanil
Proguanil hydrochloride tabs
View adult BNF View SPC online
Formulary  
   
Proguanil hydrochloride with atovaquone tabs
View adult BNF View SPC online
Formulary  
   
05.04.01  Expand sub section  Pyrimethamine
Fansidar® tabs (pyrimethamine and sulfadoxine)
View adult BNF View SPC online
Formulary  
   
05.04.01  Expand sub section  Quinine
Quinine dihydrochloride injection
View adult BNF View SPC online
Formulary
Red
 
   
Quinine sulphate tabs
View adult BNF View SPC online
Formulary  
   
05.04.01  Expand sub section  Tetracyclines
Doxycycline caps
View adult BNF View SPC online
Formulary  
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary